To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Warburg Pincus scores 3x healthcare exit
An agressive roll out of Euromedic International by Warburg Pincus and its co-investors has trebled the firm's original investment. The company has been sold to Merrill Lynch's private equity group and Ares Life Sciences for some €800m.
